THE IMMUNE CHECKPOINT ADENOSINE 2A RECEPTOR IS ASSOCIATED WITH AGGRESSIVE CLINICAL OUTCOMES AND REFLECTS AN IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT IN HUMAN BREAST CANCER

The immune checkpoint adenosine 2A receptor is associated with aggressive clinical outcomes and reflects an immunosuppressive tumor microenvironment in human breast cancer

BackgroundThe crosstalk between the immune system and cancer cells has aroused considerable interest over the past decades.To escape immune surveillance cancer cells evolve various strategies orchestrating tumor microenvironment.The discovery of the inhibitory immune checkpoints was a major breakthrough due to their crucial contribution to immune e

read more